卫生专家对美国疾病控制与预防中心（CDC）仍渴望资助一项备受谴责的疫苗试验的消息感到愤怒，该试验会让几内亚比绍的新生儿暴露于乙型肝炎病毒，使他们面临终身感染的高风险，这可能导致肝硬化、肝癌和过早死亡。
Outrage has erupted among health experts over news that the Centers for Disease Control and Prevention is still eager to fund a widely condemned vaccine trial that would expose newborns in Guinea-Bissau to hepatitis B, putting them at high risk of a lifelong infection, which can lead to liver cirrhosis, liver cancer, and premature death.
该试验因其不道德的设计于1月被曝光并引发国际强烈抗议后暂停。尽管试验仍处于暂停状态，但据《滚石》杂志报道，CDC局长办公室的工作人员在9月下旬告知该机构预算办公室预留160万美元资助该试验。这笔资金本应来自CDC全球卫生安全项目的经费，原本可能用于应对刚果民主共和国正在肆虐的埃博拉疫情等工作。
The trial was suspended in January after its unethical design came to light and drew international outcry. Although the trial is still halted, staff of the CDC director's office told the agency's budget office in late September to set aside $1.6 million to fund the trial, according to a report by Rolling Stone. The money was to be pulled from funding for the CDC's global health security programs, which might otherwise go toward efforts like combating the Ebola outbreak currently raging in the Democratic Republic of the Congo.
监管CDC的美国卫生与公众服务部未回应Ars Technica的置评请求。
The Department of Health and Human Services, which oversees the CDC, did not respond to a request for comment from Ars Technica.